8-K: Actuate Therapeutics Announces Date for Annual Stockholders Meeting

Actuate Therapeutics sets the date for its first annual stockholders meeting and outlines deadlines for stockholder proposals and director nominations.

Summary

• Actuate Therapeutics will hold its first Annual Meeting of Stockholders virtually on May 22, 2025.
• The record date for stockholders entitled to notice of and to vote at the Annual Meeting is March 25, 2025.
• The deadline for Rule 14a-8 stockholder proposals to be included in proxy materials is February 21, 2025.
• The deadline for advance notice of director nominations and other stockholder proposals is also February 21, 2025.

Sentiment

Score: 7

Explanation: The announcement is routine and provides necessary information to shareholders, indicating a neutral to slightly positive sentiment.

Positives

• The announcement provides clarity to stockholders regarding the date of the Annual Meeting and deadlines for submitting proposals and nominations.

Future Outlook

The company will provide additional details regarding the matters to be voted on and instructions for accessing the Annual Meeting in the company's proxy statement to be filed with the Securities and Exchange Commission prior to the Annual Meeting.

Industry Context

This announcement is a standard corporate governance procedure for publicly traded companies, ensuring stockholders are informed about the annual meeting and their rights to participate.

Stakeholder Impact

• Shareholders are informed about the upcoming annual meeting and deadlines for submitting proposals and nominations, enabling them to participate in corporate governance.

Next Steps

• The Company will file a proxy statement with the SEC prior to the Annual Meeting.
• Stockholders will receive instructions for accessing the virtual Annual Meeting.

Key Dates

Keywords

Annual Meeting, Stockholders, Proxy Statement, Director Nominations, Stockholder Proposals, Actuate Therapeutics